Paper published in Molecular Psychiatry advances work that began at Nemours Children’s Health. A new paper out earlier this spring from a national team of researchers has suggested an...

Research team will study the mechanisms underlying seizures and cognitive impairments in tuberous sclerosis complex WILMINGTON, Del. (June 11, 2024) — Amanda Hernan, PhD, Head of the Dynamics in...

Nemours Children’s CEO Named One of Nation’s 50 Most Influential Clinical Executives Modern Healthcare lists Dr. Lawrence Moss among elite group JACKSONVILLE, Fla. (June 10, 2024) – Modern...

Award-winning podcast ignites conversations to create the healthiest generations of children WASHINGTON, D.C. (June 4, 2024) – Well Beyond Medicine: the Nemours Children’s Health Podcast is...

Cellergy Pharma uses CAR T-cell technology developed in a Nemours laboratory to treat severe allergic diseases WILMINGTON, Del. (May 23, 2024) – Cellergy Pharma Inc., a preclinical biotechnology...